BioVentrix, Inc.

47 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

Ending by 2030

Dec 2026

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 11, 2026
The maintenance fee for Cardiac tissue penetrating devices, methods, and systems for treatment of congestive heart failure and other conditions (US 10,314,498) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
1 fee due Jan 2, 2027
The maintenance fee for Method and device for treating dysfunctional cardiac tissue (US 10,335,279) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
1 fee due Feb 4, 2027
The maintenance fee for Remote Pericardial Hemostasis for Ventricular Access and Reconstruction or Other Organ Therapies (US 9,095,363) comes due Feb 4, 2027. Unpaid by Aug 4, 2027, it lapses early.
1 fee due Mar 5, 2027
The maintenance fee for Pericardial Inflation Catheter and Systems and Methods Employing Same (US 11,744,615) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
2 fees due May 3, 2027
1 fee due Jun 15, 2027
The maintenance fee for Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states (US 9,211,115) comes due Jun 15, 2027. Unpaid by Dec 15, 2027, it lapses early.
1 fee due Aug 20, 2027
The maintenance fee for Heart anchor positioning devices, methods, and systems for treatment of congestive heart failure and other conditions (US 11,903,834) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
2 fees due Sep 3 to 17, 2027 · next Sep 3
3 fees due Oct 14 to 26, 2027 · next Oct 14

Which patents, and when each one lapses · Pro

Recent changes

9 terms have ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,022,226	Method and apparatus for closing off a portion of a heart ventricle In force Term ends Dec 25, 2026 · From the USPTO record	In force	Term ends Dec 25, 2026	From the USPTO record
US 10,478,305	Steerable lesion excluding heart implants for congestive heart failure In force Term ends Jan 12, 2027 · From the USPTO record	In force	Term ends Jan 12, 2027	From the USPTO record
US 11,331,190	Steerable lesion excluding heart implants for congestive heart failure In force Term ends Apr 29, 2027 · From the USPTO record	In force	Term ends Apr 29, 2027	From the USPTO record
US 11,259,929	Method and device for treating dysfunctional cardiac tissue In force Term ends May 7, 2027 · From the USPTO record	In force	Term ends May 7, 2027	From the USPTO record
US 11,793,643	Method and apparatus for closing off a portion of a heart ventricle In force Term ends May 15, 2027 · From the USPTO record	In force	Term ends May 15, 2027	From the USPTO record
US 9,913,719	Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states In force Ends no later than May 21, 2027 · From the USPTO record	In force	Ends no later than May 21, 2027	From the USPTO record
US 11,419,723	Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states In force Term ends Nov 12, 2027 · From the USPTO record	In force	Term ends Nov 12, 2027	From the USPTO record
US 10,335,279	Method and device for treating dysfunctional cardiac tissue In force Term ends Nov 30, 2027 · From the USPTO record	In force	Term ends Nov 30, 2027	From the USPTO record
US 10,617,525	Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states In force Term ends Dec 16, 2027 · From the USPTO record	In force	Term ends Dec 16, 2027	From the USPTO record
US 7,766,816	Method and apparatus for closing off a portion of a heart ventricle In force Term ends Jul 10, 2028 · From the USPTO record	In force	Term ends Jul 10, 2028	From the USPTO record

10 of 47 patents shown.

Pro members see all 47.

Pro members: see all 47 patents

Also on record, not counted in the 47: 7 lapsed for an unpaid fee · 21 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned

List them